Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Bank Bonds That Cut Risk Draw Ares and Blackstone: Credit Weekly
#Investment #Partners
Oct 18, 2023
finance.yahoo.com
J&J Weighs Third Bankruptcy Try to Settle Baby Powder Suits
undefined
Jun 18, 2019
en.globes.co.il
J&J to close Tel Hashomer blood bank operations
#Layoffs
Jan 12, 2016
www.globes.co.il
J&J leads $28m round in Israel's V-Wave
undefined
Jan 9, 2014
www.israel21c.org
Johnson & Johnson to establish new biotechnology incubator in Israel
#Partners #Investment
Dec 16, 2012
www.globes.co.il
Omrix obtains FDA approval for fibrin sealant
#Customers
About
Johnson & Johnson Inc engages in the research and development, manufacture, and sale of a range of products in the healthcare field. The company's segments include consumer, pharmaceutical, and medical devices. The company's primary focus is on products related to human health and wellbeing.
Johnson & Johnson has two subsidiaries in Israel with R&D operations. Biosense Webster Israel, specializing in the diagnosis and treatment of cardiac arrhythmias, was acquired in 1997. Omrix Biopharmaceuticals, which specializes in the development and manufacture of life-saving products derived from human plasma, was acquired in 2008.
In 2014, Johnson & Johnson Innovation opened a new biotechnology incubator in Israel, called FutuRx, through a publicprivate partnership.